Plasma Membrane Proteomics and Its Application in Clinical Cancer Biomarker Discovery
Open Access
- 1 July 2010
- journal article
- review article
- Published by Elsevier in Molecular & Cellular Proteomics
- Vol. 9 (7) , 1369-1382
- https://doi.org/10.1074/mcp.r900006-mcp200
Abstract
No abstract availableKeywords
This publication has 180 references indexed in Scilit:
- Glycoproteomics: Past, present and futureFEBS Letters, 2009
- Anti-epidermal growth factor receptor monoclonal antibodies in cancer treatmentCancer Treatment Reviews, 2009
- Alteration of protein glycosylation in liver diseasesJournal of Hepatology, 2008
- Differential Membrane Proteomics Using 18O-Labeling To Identify Biomarkers for CholangiocarcinomaJournal of Proteome Research, 2008
- A “class action” against the microenvironment: do cancer cells cooperate in metastasis?Cancer and Metastasis Reviews, 2007
- Serum EGFR and serum HER‐2/neu are useful predictive and prognostic markers in metastatic breast cancer patients treated with metronomic chemotherapyCancer, 2007
- Cancer proteomics by quantitative shotgun proteomicsMolecular Oncology, 2007
- Effects of chemotherapy and hormonal therapy for early breast cancer on recurrence and 15-year survival: an overview of the randomised trialsThe Lancet, 2005
- Predicting transmembrane protein topology with a hidden markov model: application to complete genomes11Edited by F. CohenJournal of Molecular Biology, 2001
- Genome‐wide analysis of integral membrane proteins from eubacterial, archaean, and eukaryotic organismsProtein Science, 1998